Live
- Previous TTD board looted pilgrims’ money, slams Bhanu
- Will order a detailed probe into TIDCO irregularities: Narayana
- Naidu all praise for Modi
- Indian students' concerns about employment, safety, and visas discourage them from applying to UK universities
- Candlelight Concerts Makes a Dazzling Debut in Hyderabad with Sold-Out 'Tribute to Coldplay' Show
- Shubman Gill Sustains Thumb Injury Ahead of Perth Test; Devdutt Padikkal Joins Test Squad
- Unlock Loot Boxes, Diamonds, Skins, and More Exciting Rewards with Garena Free Fire Max Redeem Codes for November 16
- Regarding the DOGE Plan, Vivek Ramaswamy stated, "Elon Musk and I Will Take a Chainsaw to Bureaucracy"
- Sudanese army says repulsed paramilitary forces attack in western Sudan, killing over 80
- Jaipur Open 2024: Baisoya makes a grand comeback to clinch title in marathon playoff against Rashid Khan
Pricing pressure hits pharma exports
Pharma exports from India registered a negative growth of four per cent during the first five months of the current fiscal owing to increased regulatory issues coupled with pricing pressure in global markets, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Hyderabad: Pharma exports from India registered a negative growth of four per cent during the first five months of the current fiscal owing to increased regulatory issues coupled with pricing pressure in global markets, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Udaya Bhaskar, Director General, Pharmexcil, said: “The pharma exports to other countries witnessed a decline of 7.9 per cent during the April-July period, while recovered to four per cent in August leaving the over-all growth at minus four per cent till August this year. Till July, pharma exports registered minus 7.9 per cent growth. Subsequently it recovered in August and stood at minus four per cent.
There was four per cent growth in August. Pricing pressure is one of the factors (for decline in exports). To some extent import alerts (by US FDA on Indian plants), regulatory issues and currency fluctuation, are some of the factors contributed to downward growth.” He, however, hoped that the overall exports will recover and come into positive zone for the full year as exports are expected to take an uptick from September.
